PI3K/AKT/mTOR signaling pathway dysregulation has been reported to affect gastric cancer prognosis and metastasis through epigenetic alterations, such as DNA methylation and histone modifications (Fattahi et al., 2020). This evidence concerns the gene AKT1 and gastric cancer.